As Eli Lilly and Novo Nordisk scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, much smaller potential rival Structure Therapeutics spotlighted positive ...

Honey Badger Silver is pleased to share the results from the recent geophysical survey and prospecting work completed at it's 100%-owned Nanisivik Project. Nanisivik is a former polymetallic-silver ...

December 1, 2025) - Honey Badger Silver Inc. (TSXV: TUF) (OTCQB: HBEIF) ("Honey Badger" or the "Company") is pleased to share ...